Automotive Supplier Innovation Program

SI Group Inspires Future Scientists through Event with Sheldon ISD

Retrieved on: 
星期三, 十一月 29, 2023

THE WOODLANDS, Texas, Nov. 29, 2023 /PRNewswire/ -- SI Group, a leading global developer and manufacturer of performance additives, process solutions, pharmaceuticals, and chemical intermediates, welcomed approximately 30 students enrolled in the STEM program at Sheldon Independent School District in Houston, Texas to the company's Global Innovation Center. The event was held to give students firsthand exposure to the world of chemistry and problem-solving through scientific exploration.

Key Points: 
  • The visit showcased SI Group's commitment to promoting STEM education and inspiring the next generation of scientists.
  • The partnership between our school and industry partners such as SI Group provides much more than a lesson, we are building the future workforce together."
  • "We are thrilled to have hosted these bright young minds from Sheldon ISD as part of our ongoing commitment to STEM education," said Narsi Devanathan, Vice President - Research & Development at SI Group.
  • SI Group looks forward to continuing its collaboration with local schools and educational institutions to promote STEM education and develop the next generation of innovators.

SI Group Inspires Future Scientists through Event with Sheldon ISD

Retrieved on: 
星期三, 十一月 29, 2023

THE WOODLANDS, Texas, Nov. 29, 2023 /PRNewswire/ -- SI Group, a leading global developer and manufacturer of performance additives, process solutions, pharmaceuticals, and chemical intermediates, welcomed approximately 30 students enrolled in the STEM program at Sheldon Independent School District in Houston, Texas to the company's Global Innovation Center. The event was held to give students firsthand exposure to the world of chemistry and problem-solving through scientific exploration.

Key Points: 
  • The visit showcased SI Group's commitment to promoting STEM education and inspiring the next generation of scientists.
  • The partnership between our school and industry partners such as SI Group provides much more than a lesson, we are building the future workforce together."
  • "We are thrilled to have hosted these bright young minds from Sheldon ISD as part of our ongoing commitment to STEM education," said Narsi Devanathan, Vice President - Research & Development at SI Group.
  • SI Group looks forward to continuing its collaboration with local schools and educational institutions to promote STEM education and develop the next generation of innovators.

Infor Positioned as a Leader in the Nucleus CPQ Technology Value Matrix 2023

Retrieved on: 
星期一, 十一月 27, 2023

NEW YORK, Nov. 27, 2023 /PRNewswire/ -- Infor®, the industry cloud company, today announced that Nucleus Research has positioned Infor as a Leader in its CPQ Technology Value Matrix 2023 for the fourth-consecutive year. Infor is recognized for delivering bespoke functionalities and item configurations for a diverse range of industries.

Key Points: 
  • NEW YORK, Nov. 27, 2023 /PRNewswire/ -- Infor®, the industry cloud company, today announced that Nucleus Research has positioned Infor as a Leader in its CPQ Technology Value Matrix 2023 for the fourth-consecutive year.
  • It's designed to fuel sales revenue, minimize quotation errors, and amplify market awareness through its visual configuration tools," the Nucleus CPQ Value Matrix report states.
  • Download a complimentary copy of the 2023 Nucleus Research CPQ Technology Value Matrix.
  • The Nucleus Research CPQ Technology Value Matrix is concise assessment of the operational value a solution delivers.

TCT 2023: Six-Month Clinical Data from DESyne® BDS Plus Randomized Controlled Trial (RCT) Support Safety and Effectiveness of World’s First Site-Specific Antithrombotic Drug Therapy

Retrieved on: 
星期三, 十月 25, 2023

At six months, TLF rate was 1.0% for DESyne BDS Plus and 8.2% (p=0.035; 95%CI, -14.8% to -1.3%) for the durable polymer DES.

Key Points: 
  • At six months, TLF rate was 1.0% for DESyne BDS Plus and 8.2% (p=0.035; 95%CI, -14.8% to -1.3%) for the durable polymer DES.
  • No definite or probable stent thrombosis, target vessel myocardial infarction or cardiovascular deaths were observed with DESyne BDS Plus study device.
  • The DESyne BDS Plus RCT is a prospective, multicenter, randomized, single-blind study of 202 patients across 14 sites.
  • A pharmacokinetic clinical sub-study was conducted to assess the blood pharmacokinetics of sirolimus, rivaroxaban and argatroban eluted from the DESyne BDS Plus device after implantation.

Marelli named Top Innovator at CLEPA Innovation Awards with its Diorama Display, pioneering head-up display enhancing safety

Retrieved on: 
星期四, 十月 19, 2023

DETRIOIT, Oct. 19, 2023 /PRNewswire/ -- Marelli has been named a 'Top Innovator' at the Innovation Awards 2023 by CLEPA, the European Association of Automotive Suppliers, with its Diorama Display technology.

Key Points: 
  • DETRIOIT, Oct. 19, 2023 /PRNewswire/ -- Marelli has been named a 'Top Innovator' at the Innovation Awards 2023 by CLEPA, the European Association of Automotive Suppliers, with its Diorama Display technology.
  • The Marelli solution was recognized in the 'Digital' category, during the awards ceremony held on October 18.
  • The CLEPA Innovation Awards celebrate the innovative excellence of the European automotive supply industry.
  • The position and distance of Diorama from the driver improve eye focus and driver reaction time, enhancing safety.

AMSilk appoints Gudrun Vogtentanz as Chief Scientific Officer

Retrieved on: 
星期二, 十月 17, 2023

MUNICH, Oct. 17, 2023 /PRNewswire/ -- AMSilk GmbH ("AMSilk"), the world's first industrial supplier of bio-based performance materials, today announces the appointment of Gudrun Vogtentanz as Chief Scientific Officer (CSO).

Key Points: 
  • MUNICH, Oct. 17, 2023 /PRNewswire/ -- AMSilk GmbH ("AMSilk"), the world's first industrial supplier of bio-based performance materials, today announces the appointment of Gudrun Vogtentanz as Chief Scientific Officer (CSO).
  • Ulrich Scherbel, Chief Executive Officer of AMSilk, said: "Gudrun's skills and experience in designing proteins and accelerating time-to-market are of significant importance for AMSilk in the current scale-up phase."
  • Gudrun Vogtentanz, Chief Scientific Officer of AMSilk, added: "AMSilk's protein-based products unlock the secrets of spider silk to create engineerable structures and solutions.
  • I am excited to join AMSilk, and look forward to making a difference in sustainability while simultaneously delivering high-performance products."

AMSilk appoints Gudrun Vogtentanz as Chief Scientific Officer

Retrieved on: 
星期二, 十月 17, 2023

MUNICH, Oct. 17, 2023 /PRNewswire/ -- AMSilk GmbH ("AMSilk"), the world's first industrial supplier of bio-based performance materials, today announces the appointment of Gudrun Vogtentanz as Chief Scientific Officer (CSO).

Key Points: 
  • MUNICH, Oct. 17, 2023 /PRNewswire/ -- AMSilk GmbH ("AMSilk"), the world's first industrial supplier of bio-based performance materials, today announces the appointment of Gudrun Vogtentanz as Chief Scientific Officer (CSO).
  • Ulrich Scherbel, Chief Executive Officer of AMSilk, said: "Gudrun's skills and experience in designing proteins and accelerating time-to-market are of significant importance for AMSilk in the current scale-up phase."
  • Gudrun Vogtentanz, Chief Scientific Officer of AMSilk, added: "AMSilk's protein-based products unlock the secrets of spider silk to create engineerable structures and solutions.
  • I am excited to join AMSilk, and look forward to making a difference in sustainability while simultaneously delivering high-performance products."

Elixir Medical To Present Randomized Clinical Dataset Featuring World’s First Triple Drug-Eluting Coronary Implant Eluting Two Anticoagulants and Sirolimus at TCT 2023

Retrieved on: 
星期四, 十月 5, 2023

The data compare DESyne BDS Plus, the world’s first triple drug-eluting stent with local anticoagulation delivery technology using two anticoagulants (rivaroxaban and argatroban) and an anti-proliferative mTOR inhibitor (sirolimus) to a second-generation durable polymer DES.

Key Points: 
  • The data compare DESyne BDS Plus, the world’s first triple drug-eluting stent with local anticoagulation delivery technology using two anticoagulants (rivaroxaban and argatroban) and an anti-proliferative mTOR inhibitor (sirolimus) to a second-generation durable polymer DES.
  • “Stent thrombosis after percutaneous coronary intervention (PCI), though rare, is a severe complication with death or heart attack risk of up to 50% after the event.
  • An imaging subset of 60 patients had angiographic and optical coherence tomography (OCT) assessment completed at six months.
  • Elixir Medical is also hosting the scientific symposium, “Innovation for PCI: Improved outcomes require disruption” featuring a panel of speakers including Robert W. Yeh, M.D., Mirvat Alasnag, M.D, Ignacio Cruz-Gonzalez, M.D., Ph.D., Roxana Mehran, M.D.

Children get physical activity boost with online resource

Retrieved on: 
星期三, 十月 4, 2023

By adding daily opportunities for active play in childcare and early years centres, children develop the foundations for healthy cognitive, emotional, social, and physical development.

Key Points: 
  • By adding daily opportunities for active play in childcare and early years centres, children develop the foundations for healthy cognitive, emotional, social, and physical development.
  • A recent study showed that children who participate in play-based physical literacy programming learn to love moving and become happier and better behaved.
  • Designed to break down barriers to physical literacy, ActivePlay.ca provides tips for inexpensive ways to create a safe learning environment that promotes movement.
  • Active for Life is a Canadian not-for-profit social initiative that helps parents and educators give children a healthy start in life through the development of physical literacy.

SBA Announces 15 Appointees to New Invention, Innovation, and Entrepreneurship Federal Advisory Committee

Retrieved on: 
星期四, 九月 28, 2023

The advisory committee’s main objective is to promote, expand, and strengthen the innovation ecosystem, including innovation commercialization, lab-to-market translation, and constructing a more equitable, inclusive federal innovation ecosystem.

Key Points: 
  • The advisory committee’s main objective is to promote, expand, and strengthen the innovation ecosystem, including innovation commercialization, lab-to-market translation, and constructing a more equitable, inclusive federal innovation ecosystem.
  • Timothy Tiemann, Managing Director of Innovation Programs, California State University Northridge (Calif.)
    Additional information about the Invention, Innovation, and Entrepreneurship Advisory Committee can be found at Invention, Innovation, and Entrepreneurship Advisory Committee (sba.gov) .
  • The SBA will announce additional IIEAC members and public meeting dates in the coming weeks.
  • Members of the advisory committee do not receive a salary, nor are they eligible to officially represent the SBA.